Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Solid Biosciences (SLDB) Depreciation and Depletion (2017 - 2023)

Solid Biosciences' Depreciation and Depletion history spans 7 years, with the latest figure at $587000.0 for Q4 2023.

  • For Q4 2023, Depreciation and Depletion rose 8.91% year-over-year to $587000.0; the TTM value through Dec 2023 reached $2.6 million, up 7.18%, while the annual FY2023 figure was $2.6 million, 7.18% up from the prior year.
  • Depreciation and Depletion for Q4 2023 was $587000.0 at Solid Biosciences, roughly flat from $588000.0 in the prior quarter.
  • Across five years, Depreciation and Depletion topped out at $1.3 million in Q2 2020 and bottomed at $438000.0 in Q3 2022.
  • The 5-year median for Depreciation and Depletion is $720000.0 (2021), against an average of $734950.0.
  • The largest annual shift saw Depreciation and Depletion skyrocketed 162.56% in 2019 before it crashed 46.18% in 2021.
  • A 5-year view of Depreciation and Depletion shows it stood at $806000.0 in 2019, then fell by 1.24% to $796000.0 in 2020, then dropped by 4.52% to $760000.0 in 2021, then fell by 29.08% to $539000.0 in 2022, then rose by 8.91% to $587000.0 in 2023.
  • Per Business Quant, the three most recent readings for SLDB's Depreciation and Depletion are $587000.0 (Q4 2023), $588000.0 (Q3 2023), and $703000.0 (Q2 2023).